Published in Ther Adv Urol on December 16, 2015
Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med (2002) 7.85
The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen Pharmacol (1988) 3.33
AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol (2011) 3.00
Selective activation of NF-kappa B by nerve growth factor through the neurotrophin receptor p75. Science (1996) 2.15
The role of the urinary epithelium in the pathogenesis of interstitial cystitis/prostatitis/urethritis. Urology (2007) 1.79
Community-onset urinary tract infections: a population-based assessment. Infection (2007) 1.34
Anandamide-evoked activation of vanilloid receptor 1 contributes to the development of bladder hyperreflexia and nociceptive transmission to spinal dorsal horn neurons in cystitis. J Neurosci (2004) 1.30
A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology (1996) 1.13
The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol (2002) 1.11
Abnormal excitability in capsaicin-responsive DRG neurons from cats with feline interstitial cystitis. Exp Neurol (2005) 1.10
Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study. Am J Infect Control (2014) 1.08
Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int (2013) 1.07
Hyaluronic acid: an effective alternative treatment of interstitial cystitis, recurrent urinary tract infections, and hemorrhagic cystitis? Eur Urol (2007) 1.01
Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol (1996) 1.01
Long-term results of intravesical hyaluronan therapy in bladder pain syndrome/interstitial cystitis. Int Urogynecol J (2010) 0.98
Impact of intravesical hyaluronic acid and chondroitin sulfate on bladder pain syndrome/interstitial cystitis. Int Urogynecol J (2011) 0.96
Prevention of recurrent urinary tract infections by intravesical administration of hyaluronic acid and chondroitin sulphate: a placebo-controlled randomised trial. Eur Urol (2011) 0.93
A combined intravesical therapy with hyaluronic acid and chondroitin for refractory painful bladder syndrome/interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.93
Comparison of intravesical hyaluronic acid instillation and hyperbaric oxygen in the treatment of radiation-induced hemorrhagic cystitis. BJU Int (2011) 0.93
Contemporary management of uncomplicated urinary tract infections. Drugs (2008) 0.92
Prevention of recurrent bacterial cystitis by intravesical administration of hyaluronic acid: a pilot study. BJU Int (2004) 0.91
Prevention of recurrent bacterial urinary tract infections by intravesical instillation of hyaluronic acid. Int J Gynaecol Obstet (2007) 0.88
The therapeutic challenge of "chronic cystitis": search well, work together, and gain results. Eur Urol (2011) 0.85
Intravesical hyaluronic acid and chondroitin sulphate for bladder pain syndrome/interstitial cystitis: long-term treatment results. Int Urogynecol J (2012) 0.84
Morphological changes of bladder mucosa in patients who underwent instillation with combined sodium hyaluronic acid-chondroitin sulphate (Ialuril®). Urol Int (2013) 0.83
Effectiveness of intravesical hyaluronic acid/chondroitin sulfate in recurrent bacterial cystitis: a randomized study. Int Urogynecol J (2012) 0.82
Results of endovesical hyaluronic acid/chondroitin sulfate in the treatment of Interstitial Cystitis/Painful Bladder Syndrome. Rev Recent Clin Trials (2008) 0.82
Combined intravesical sodium hyaluronate/chondroitin sulfate therapy for interstitial cystitis/bladder pain syndrome: a prospective study. Ther Adv Urol (2013) 0.82
Could hyaluronic acid (HA) reduce Bacillus Calmette-Guérin (BCG) local side effects? Results of a pilot study. BMC Urol (2014) 0.78
Hyaluronic acid-chondroitin sulfate: a potential factor to select pure stress urinary incontinence in patients with interstitial cystitis⁄painful bladder syndrome and mixed incontinence symptoms. Minerva Ginecol (2015) 0.78
Sodium hyaluronate and chondroitin sulfate replenishment therapy can improve nocturia in men with post-radiation cystitis: results of a prospective pilot study. BMC Urol (2015) 0.78
The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review. Taiwan J Obstet Gynecol (2015) 0.77
Editorial comment on: A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature. Eur Urol (2009) 0.77
Intravesical therapy in recurrent cystitis: a multi-center experience. J Infect Chemother (2013) 0.77
Intravesical treatment with highly-concentrated hyaluronic acid and chondroitin sulphate in patients with recurrent urinary tract infections: Results from a multicentre survey. Can Urol Assoc J (2014) 0.76
Clinical Experience with Urethral Reconstruction Using Tissue-engineered Oral Mucosa: A Quiet Revolution. Eur Urol (2015) 2.74
Correlation Between Primary Hypospadias Repair and Subsequent Urethral Strictures in a Series of 408 Adult Patients. Eur Urol Focus (2017) 0.77
One-stage Penile Urethroplasty Using Oral Mucosal Graft and Glue. Eur Urol (2016) 0.75
Memokath Stent Failure in Recurrent Bulbar Urethral Strictures: Results from an Investigative Pilot Stage 2a Study. Urology (2017) 0.75
Three-Dimensional Computerized Model Based on the Sonourethrogram: A Novel Technique for Evaluating the Anterior Urethral Stricture. J Urol (2017) 0.75